Page last updated: 2024-08-26

alpha-glutamyltryptophan and Cancer of Liver

alpha-glutamyltryptophan has been researched along with Cancer of Liver in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Blann, A; Christodoulos, K; Deplanque, G; Ganesan, TS; Harris, AL; Jones, PH; Madhusudan, S; Talbot, DC; Wellmann, S	1

Trials

1 trial(s) available for alpha-glutamyltryptophan and Cancer of Liver

Article	Year
Phase II trial of the antiangiogenic agent IM862 in metastatic renal cell carcinoma. British journal of cancer, 2004, Nov-01, Volume: 91, Issue:9 Topics: Adult; Aged; Angiogenesis Inhibitors; Bone Neoplasms; Carcinoma, Renal Cell; Dipeptides; Disease Progression; Female; Humans; Kidney Neoplasms; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neovascularization, Pathologic; Prospective Studies; Time Factors	2004

Article

Year

Phase II trial of the antiangiogenic agent IM862 in metastatic renal cell carcinoma.

British journal of cancer, 2004, Nov-01, Volume: 91, Issue:9

Topics: Adult; Aged; Angiogenesis Inhibitors; Bone Neoplasms; Carcinoma, Renal Cell; Dipeptides; Disease Progression; Female; Humans; Kidney Neoplasms; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neovascularization, Pathologic; Prospective Studies; Time Factors

2004